|
|
 |
|
Viewing report
|
|
|
|
Healthcare Review: Cancer - September 2002
Datamonitor, Feb 2002
The Cancer Review brings you the latest news, analysis and research in the cancer industry. It covers all the major current business issues and events, including R&D, licensing deals, alliances and joint ventures, and regulatory decisions.Strategic insight into the future shape of cancer companies and marketsThe most significant cancer industry news compiled into one monthly updateExpert analysis into the implications of the month's important cancer industry eventsInsight into the future shape of the market for players at all levelsAll the month's major cancer stories in headline and summary formOut of the dozens of topics covered in this month's review, the most important include:* Japan became the first country to approve AstraZeneca's Iressa for the treatment of inoperable or recurrent non-small cell lung cancer. Iressa is the first in a new class of anti-cancer drugs, known as EGF receptor inhibitors.* Five non-profitable UK biotech companies may be considering a merger, creating a new cancer player capable of competing against the majors. But a more gradual consolidation effort might suit the biotechs betterNot only keeps you updated about industry events - it also gives you opinion and insightDraws upon Datamonitor analysts' extensive experience to bring you our perspective on the impact of the latest eventsProvides you with your own news archive to track company and industry progress, giving you an extensive reference to relevant events and issues
Customers who bought this item also bought
Healthcare Review: Cancer - October 2002
Cancer Diagnostic Testing World Markets
Cancer Drug Discoveries: What the Future Holds: Non-Small Cell Lung Cancer Chapter
Cancer Drug Discoveries: What the Future Holds: Prostate Cancer Chapter
The Cancer Market Outlook to 2012
Cancer Drug Resistance
Apoptosis 2009: Opportunities in Cancer and Other Diseases
Cancer Vaccine Developments to 2013 + Cancer Vaccine Tracker
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
Cancer Therapies - Global Strategic Business Report
Cancer Therapeutics Markets
The Cancer Market Outlook to 2013: Competitive Landscape, Pipeline Analysis and Growth Opportunities
|
|
|
|
